Jeff Boyle | Head-Investor Relations |
Mike Cloonan | Chief Operating Officer |
Jim Doherty | Chief Research Officer |
Kimi Iguchi | Chief Financial Officer |
Steve Kanes | Chief Medical Officer |
Turner Kufe | JPMorgan |
Salveen Richter | Goldman Sachs |
Lyla Youssef | Cowen |
Marc Goodman | SVB Leerink |
Andrew Tsai | Jefferies |
Leo Ma | Wolfe Research |
Leo Timashev | RBC Capital Markets |
Laura Chico | Wedbush Securities |
Jiunn Chiu | Morgan Stanley |
Jay Olson | Oppenheimer |
Rafay Sardar | BMO Capital Markets |
Chris Bialas | H.C. Wainwright |
Good morning. Welcome to Sage Therapeutics’ Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please note that this call is being recorded. I would now like to introduce Jeff Boyle, Head of Investor Relations at Sage.
Good morning, everyone, and thank you for joining Sage Therapeutics’ third quarter 2020 financial results conference call.